Purpose
Therapeutic Drug Monitoring
Method(s)
Spectrophotometry (SP)
Suggested CPT Code(s)
80375
New York State Approval Status

Approved

Known Interference(s)
Sulfonamides [SP]: Acetaminophen; Benzocaine; Furosemide; Lidocaine; para-aminobenzoic acid; Thaizide diuretics
Turnaround Time

8 days

Test Includes
1 Sulfonamides Spectrophotometry (SP) mcg/mL 5 Antibacterial Acetaminophen; Benzocaine; Furosemide; Lidocaine; para-aminobenzoic acid; Thaizide diuretics

Test Also Known As
sulfadiazine; sulfamethizole; sulfamethoxazole; sulfapyridine; sulfasalazine; sulfisoxazole
Specimen Type
Urine
Requested Volume
1 mL
Minimum Volume
0.4 mL
Special Handling
Dark or discolored urine samples may interfere with this analysis.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 7 day(s)
Refrigerated: 7 day(s)
Frozen (-20 °C): 4 month(s)
1 Sulfonamides Spectrophotometry (SP) mcg/mL 5 Antibacterial Acetaminophen; Benzocaine; Furosemide; Lidocaine; para-aminobenzoic acid; Thaizide diuretics

Interface Map

LOINC® Information